← All stories
Health, Longevity & Biohacking

Mukherjee describes correlational CT-scan analysis where thymus presence tracked with fewer diseases including cancer

By Egleze Editorial Desk · Published October 19, 2026 · Peter Attia Drive · 412 ‒ The evolving science of cancer: emerging approaches to prevention and early detection, & more
Mukherjee describes correlational CT-scan analysis where thymus presence tracked with fewer diseases including cancer
Peter Attia Drive
Peter Attia Drive
412 ‒ The evolving science of cancer: emerging approaches to prevention and early detection, & more

What was said

"And they found one marker. And it was the presence or absence of an organ called the thymus."

Siddhartha Mukherjee says he recently heard a talk about using AI to analyse CT scans for features that correlate with outcomes such as longevity and disease. He says one reported marker was the presence or absence of the thymus, adding that in the work he described, people with an “intact thymus” tended to have fewer diseases including cancer, while emphasising the result was correlational rather than causal.

Verification status

Attributed speaker claim

Egleze verified who said this and where. The underlying claim has not been independently established by Egleze.

Source and context

Egleze verified who said this and where. The underlying claim has not been independently established by Egleze.

Speaker
Siddhartha Mukherjee · guest
Programme
Peter Attia Drive
Episode
412 ‒ The evolving science of cancer: emerging approaches to prevention and early detection, & more
Clip time
58:18
Original source
Watch the source segment →
From this episode
Peter Attia Drive
Peter Attia Drive

412 ‒ The evolving science of cancer: emerging approaches to prevention and early detection, & more

2h 4m · 7 Egleze moments
Read episode summary and key points →

More moments from this episode

Health, Longevity & BiohackingMukherjee says early-onset colorectal cancer rise remains a mystery→Health, Longevity & BiohackingMukherjee says US cancer mortality is falling, but younger colorectal cases rise→Health, Longevity & BiohackingMukherjee says CD19 CAR-T also wipes out healthy B cells→Health, Longevity & BiohackingMukherjee says GLP-1 add-on cancer trials should be randomised→
More stories More from Peter Attia Drive